These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26871550)

  • 1. A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 Phototherapy.
    Lazzeri L; Tripo L; Pescitelli L; Ricceri F; Prignano F
    Pediatr Dermatol; 2016; 33(2):e99-102. PubMed ID: 26871550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease.
    Calzavara Pinton P; Porta F; Izzi T; Venturini M; Capezzera R; Zane C; Notarangelo LD
    Haematologica; 2003 Oct; 88(10):1169-75. PubMed ID: 14555314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy.
    Lazar J; Poonawalla T; Teng JM
    Pediatr Dermatol; 2011; 28(2):172-5. PubMed ID: 21504445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annular plaques: An unusual manifestation of graft-versus-host disease.
    Alexander LJ; Paravar T; Duvic M; Prieto V; Hymes SR
    Dermatol Online J; 2012 Jun; 18(6):4. PubMed ID: 22747928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Invest Dermatol; 2016 Nov; 136(11):2158-2167. PubMed ID: 27424318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective.
    Molés-Poveda P; Montesinos P; Sanz-Caballer J; de Unamuno B; Piñana JL; Sahuquillo A; Botella-Estrada R
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):241-247. PubMed ID: 29254596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease.
    Ghoreschi K; Thomas P; Penovici M; Ullmann J; Sander CA; Ledderose G; Plewig G; Kolb HJ; Röcken M
    Eur J Dermatol; 2008; 18(6):667-70. PubMed ID: 18955201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
    Kim JB; Liakopoulou E; Watson JS
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD.
    George L; George B; Gottlieb DJ; Hertzberg M; Fernandez-Peñas P
    Bone Marrow Transplant; 2012 May; 47(5):737-8. PubMed ID: 21785472
    [No Abstract]   [Full Text] [Related]  

  • 12. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges.
    White JM; Creamer D; du Vivier AW; Pagliuca A; Ho AY; Devereux S; Salisbury JR; Mufti GJ
    Br J Dermatol; 2007 May; 156(5):1032-8. PubMed ID: 17419693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phototherapy for the treatment of cutaneous graft versus host disease.
    Garbutcheon-Singh KB; Fernández-Peñas P
    Australas J Dermatol; 2015 May; 56(2):93-9. PubMed ID: 25302552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PUVA therapy for cutaneous acute graft-versus-host disease--a case report].
    Inamitsu T; Inoue M; Akiyoshi H; Honda K; Shibuya T; Nakayama H; Ueda K
    Rinsho Ketsueki; 1995 Nov; 36(11):1321-5. PubMed ID: 8691576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
    Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
    Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
    [No Abstract]   [Full Text] [Related]  

  • 16. Sclerodermatous changes of chronic graft-versus-host-disease treated with puva.
    Woscoff A; Ruíz Lascano A; De Pablo AB; Robinson A
    Int J Dermatol; 1996 Sep; 35(9):656-8. PubMed ID: 8876297
    [No Abstract]   [Full Text] [Related]  

  • 17. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
    Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
    Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
    Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.
    Eppinger T; Ehninger G; Steinert M; Niethammer D; Dopfer R
    Transplantation; 1990 Nov; 50(5):807-11. PubMed ID: 2238056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sclerodermatous cutaneous reaction of graft vs host disease treated with thalidomide].
    Pédailles S; Troussard X; Launay V; Bazin A; Sentias C; Surbled M
    Presse Med; 1993 Jan 2-16; 22(1):37. PubMed ID: 8469665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.